These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11683239)

  • 1. Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase.
    DeGraw RT; Anderson BD
    Pharm Res; 2001 Sep; 18(9):1270-6. PubMed ID: 11683239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of the local inhibition of intestinal adenosine deaminase (ADA) by erythro-9-(2-hydroxy-3-nonyl)adenine: enhanced oral delivery of an ADA-activated prodrug for anti-HIV therapy.
    Singhal D; Anderson BD
    J Pharm Sci; 1998 May; 87(5):578-85. PubMed ID: 9572908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
    Singhal D; Ho NF; Anderson BD
    J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of carrier-mediated transport of 2',3'-dideoxypurine nucleosides in the rat ileum using a bidirectional perfusion technique.
    DeGraw RT; Anderson BD
    Pharm Res; 2004 Feb; 21(2):300-8. PubMed ID: 15032312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of inhibition of calf intestinal adenosine deaminase by (+)- and (-)-erythro-9-(2-hydroxy-3-nonyl)adenine.
    Porter DJ; Abushanab E
    Biochemistry; 1992 Sep; 31(35):8216-20. PubMed ID: 1525161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-pass disposition of (-)-6-aminocarbovir in rats: II. Inhibition of intestinal first-pass metabolism.
    Zimmerman CL; Wen Y; Remmel RP
    Drug Metab Dispos; 2000 Jun; 28(6):672-9. PubMed ID: 10820140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition.
    Roth JS; McCully CM; Balis FM; Poplack DG; Kelley JA
    Drug Metab Dispos; 1999 Oct; 27(10):1128-32. PubMed ID: 10497138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute cardiotoxicity of the Anti-HIV dideoxynucleoside, F-ddA, in the rat.
    Donzanti BA; Kelley JA; Tomaszewski JE; Roth JS; Tosca P; Placke M; Singer A; Yarrington JT; Driscoll JS
    Fundam Appl Toxicol; 1995 Sep; 27(2):167-76. PubMed ID: 8529811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cycloSal-Pronucleotides of 2'-fluoro-ara- and 2'-fluoro-ribo-2',3'- dideoxyadenosine as a strategy to bypass a metabolic blockade.
    Meier C; Knispel T; Marquez VE; Siddiqui MA; De Clercq E; Balzarini J
    J Med Chem; 1999 May; 42(9):1615-24. PubMed ID: 10229630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the mechanism of enhancement of central nervous system delivery of 2'-beta-fluoro-2',3'-dideoxyinosine via a blood-brain barrier adenosine deaminase-activated prodrug.
    Johnson MD; Chen J; Anderson BD
    Drug Metab Dispos; 2002 Feb; 30(2):191-8. PubMed ID: 11792690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Lupidi G; Riva F
    J Med Chem; 1984 Mar; 27(3):274-8. PubMed ID: 6699873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of lodenosine and its major metabolite in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Roth JS; Wang J; Kelley JA
    J Mass Spectrom; 2000 Nov; 35(11):1313-9. PubMed ID: 11114090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Cristalli G; Eleuteri A; Franchetti P; Grifantini M; Vittori S; Lupidi G
    J Med Chem; 1991 Mar; 34(3):1187-92. PubMed ID: 2002459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.
    Koudriakova T; Manouilov KK; Shanmuganathan K; Kotra LP; Boudinot FD; Cretton-Scott E; Sommadossi JP; Schinazi RF; Chu CK
    J Med Chem; 1996 Nov; 39(23):4676-81. PubMed ID: 8917656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the anti-HIV-1 activity of ddAdo by coformycin, EHNA and deaza-EHNA derivatives.
    Marongiu ME; Pani A; Tinti E; Grifantini M; Franchetti P; Cristalli G; La Colla P
    New Microbiol; 1995 Oct; 18(4):359-70. PubMed ID: 8590388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
    Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R
    Pharmacol Res; 2007 Aug; 56(2):124-31. PubMed ID: 17574432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 6-alkoxypurine 2',3'-dideoxynucleosides as inhibitors of the cytopathic effect of the human immunodeficiency virus.
    Burns CL; St Clair MH; Frick LW; Spector T; Averett DR; English ML; Holmes TJ; Krenitsky TA; Koszalka GW
    J Med Chem; 1993 Feb; 36(3):378-84. PubMed ID: 8426365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice.
    Lambe CU; Nelson DJ
    Biochem Pharmacol; 1982 Feb; 31(4):535-9. PubMed ID: 7066021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.